ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1597–1608 of 2020 project topics
Atrial Fibrillation Genetic Predisposition Screening Tool Suite
An integrated diagnostic toolkit detecting rare and common genetic variants linked to familial atrial fibrillation and cardioembolic stroke risk. This generates B2B revenue through EHR integration licensing, anticoagulation stratification algorithms, and clinical trial recruitment partnerships.
Genetic Testing for Familial Stroke Click to view more details →
Mitochondrial DNA Mutation Detection Engine for Stroke Risk
A specialized sequencing and bioinformatics service identifying pathogenic mitochondrial variants in MELAS and related maternal inheritance stroke syndromes. Commercial value derives from high-cost specialized testing, genetic counseling service bundles, and family screening revenue expansion.
Genetic Testing for Familial Stroke Click to view more details →
Thrombophilia Gene Variant Marketplace and Risk Aggregation API
A B2B API platform that consolidates Factor V Leiden, prothrombin, and other thrombosis-related genetic data for laboratory and clinic integration into stroke prevention workflows. Revenue scales through per-test API calls, white-label licensing, and data licensing to pharmaceutical companies.
Genetic Testing for Familial Stroke Click to view more details →
Cerebral Autosomal Dominant Arteriopathy Longitudinal Monitoring Service
A digital health platform providing serial genetic testing, imaging biomarker integration, and longitudinal risk tracking for CADASIL and CARASIL patients across distributed care networks. This creates recurring revenue through subscription-based patient monitoring, clinical trial recruitment, and pharmaceutical collaboration fees.
Genetic Testing for Familial Stroke Click to view more details →
C3 Glomerulopathy Complement Gene Testing
Testing CFH, CFI, C3, CFB, and CFHR variants in C3 glomerulopathy for molecular diagnosis and eculizumab versus MPGN treatment guidance.
Genetic Basis of Complement Disorders Click to view more details →
Hereditary Angioedema C1-Inhibitor Gene Analysis
Characterizing SERPING1 variants causing HAE type I and II and testing F12 mutations causing estrogen-sensitive HAE for molecular classification.
Genetic Basis of Complement Disorders Click to view more details →
Complement Factor Deficiency Gene Testing
Developing gene panels for complement component deficiencies predisposing to Neisseria infections and SLE for molecular diagnosis.
Genetic Basis of Complement Disorders Click to view more details →
PNH Somatic PIGA Mutation Clonal Analysis
Applying next generation sequencing for sensitive PIGA somatic mutation detection and clonal size quantification in PNH diagnosis and monitoring.
Genetic Basis of Complement Disorders Click to view more details →
MASP2 Gene Mutation Detection Platform for Lectin Pathway
A diagnostic SaaS platform that sequences and identifies pathogenic MASP2 variants associated with lectin complement pathway deficiencies using AI-powered variant interpretation. This enables laboratories to offer specialized testing services with higher throughput, reducing turnaround time and expanding their complement disorder testing portfolio for increased revenue.
Genetic Basis of Complement Disorders Click to view more details →
Complement Factor I Gene Variant Commercial Screening Tool
An automated genotyping and phenotyping tool that identifies Factor I mutations linked to membranoproliferative glomerulonephritis and C3 dysregulation disorders. The platform generates reportable findings and billing codes, allowing diagnostic companies to monetize rare disease testing with higher accuracy and reimbursement rates.
Genetic Basis of Complement Disorders Click to view more details →
CD55 and CD46 Deficiency Gene Panel Testing Service
A commercial multi-gene testing panel that detects mutations in decay-accelerating factor and membrane cofactor protein genes responsible for acquired and inherited complement disorders. This targeted service enables clinical laboratories to capture market share in rare disease diagnostics while offering bundled testing at competitive prices.
Genetic Basis of Complement Disorders Click to view more details →
Properdin Gene X-Linked Deficiency Commercial Analysis Suite
A specialized molecular diagnostics suite with proprietary algorithms for detecting hemizygous and heterozygous properdin mutations in immunocompromised patient populations. The platform supports sex-linked inheritance interpretation and family segregation analysis, creating recurring testing revenue from multi-family screening and preventive medicine applications.
Genetic Basis of Complement Disorders Click to view more details →